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SYSTEMIC AND PULMONARY INFLAMMATORY RESPONSE ASSOCIATED WITH 
OPEN HEART SURGERY INVOLVING CARDIO-PULMONARY BYPASS; 
CHANGES IN CYTOKINE BALANCE AND PULMONARY FUNCTION 
 
 
 
 
 
 INTRODUCTION 
 
 
Year 2003 celebrated the 50th anniversary of the development of 
cardiopulmonary bypass (CPB) technology that has been one of the greatest 
advancements in cardiovascular surgery, and also established the technical 
background of heart and lung transplantation.  
However, routine cardiac operations involving cardio-pulmonary bypass are 
often associated with postoperative complications related to blood contact with foreign 
surface and resultant activation of blood leukocytes and pro-inflammatory cytokines 
collectively termed systemic inflammatory response (SIRS). Cytokines play a critical 
role as signalling molecules that set off, intensify, and terminate local and systemic 
inflammatory responses. Among these proteins, tumour necrosis factor (TNFα) and 
interleukin-1 (IL-1β) are particularly important since they can be stimulated by a broad 
spectrum of stimuli, and are able to act on a large number of effectors. 
According to numerous studies, specific and non-specific cytokine antagonists 
have also been described in the plasma of patients undergoing coronary surgery 
providing potential mechanisms for limiting the biologic effects of pro-inflammatory 
cytokines. Soluble TNF receptors bind TNF in the plasma and thus preclude it from 
binding to its transmembranous receptors, while IL-1 receptor antagonists occupies IL-
1 receptors without any signal-transduction effect. 
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The vascular endothelium is known to be one of the main targets of 
postoperative ischaemia-reperfusion injuries, coagulopathies or systemic inflammatory 
responses. On the other hand, acting as a mediator organ it alters the postoperative 
outcome of cardiac patients through inducible genes and enzymes located in the 
endothelium.  
Nitric Oxide (NO) plays an important role in both the physiological control of 
lung function and in the pathophysiology of several lung diseases. Pulmonary vascular 
endothelial cells and airway epithelial cells continuously generate NO from the 
terminal guanidino group of the amino acid L-arginine, the physiological precursor of 
NO by the action of NO synthases. In the lung NO acts both directly and through the 
soluble guanyl cyclase – cyclic GMP pathway. As endogenous production of NO can 
be detected and monitored in the exhaled air, it has become a valuable diagnostic and 
monitoring tool in chronic lung pathologies.   
It is widely accepted that two prominent cytokine- responsible pathways are the 
inducible NO and HO-CO system. These pathways are up regulated with increased 
generation of the products of these inducible enzymes in both systemic and local 
pulmonary inflammation. Thus, exhaled NO is increased in models of septic shock and 
in critically ill patients with ventilator associated pulmonary infections.  
Out of three known isoforms of heme oxygenase enzymes HO-1 is inducible by 
a broad spectrum of stimuli like hypoxia, hyperoxia, cytokines, endotoxins or UV-
radiation. Similarly to NO, CO in low concentrations (bellow 0.01%) acts through the 
soluble guanyl cyclase – cyclic GMP pathway regulating the vasomotor tone, and has 
anti-inflammatory properties. Exhaled CO has also been suggested as marker of 
pulmonary inflammation in critically ill patients.  
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AIMS 
 
 
1. Measuring the levels of pro- and anti-inflammatory cytokines in patients’ plasma 
before and after routine cardiac surgery involving cardiopulmonary bypass. 
Establishing the net inflammatory balance represented by the relationships between 
ratios of pro- and anti-inflammatory mediators and their physiological significance in 
contributing to systemic vasodilatation and pulmonary dysfunction routinely associated 
with cardiac surgery. 
 
2. Our aim was to clarify the influence and final physiological consequences of the 
exact cytokine balance or imbalance associated with cardiac surgery in human 
vascular endothelial by utilising endothelial cell-based in vitro bioassays where 
endothelial cell activation and apoptosis could be monitored in response to plasma 
from patients undergoing coronary operations. 
 
3. Vast amounts of data indicate that pro-inflammatory conditions effectively up 
regulate the inducible NO and heme oxygenase (HO) systems leading to increased 
production of NO and carbon monoxide (CO), respectively. On the basis of recent 
recognition of measurement techniques and diagnostic acceptance of these molecules 
in the exhaled breath as measure of pulmonary inflammation, we reasoned that 
monitoring exhaled NO and CO in patients undergoing open heart surgery would be 
another way to evaluate in vivo consequences of net cytokine imbalance. 
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CYTOKINE BALANCE IN PATIENTS UNDERGOING ROUTINE CARDIAC 
SURGERY UTILISING CARDIO-PULMONARY BYPASS 
 
 
Methods 
 
40 ml venous blood was collected from each patient pre CPB following 
placement of central venous catheter (control) and 6 hr after initiation of CPB. 
To study whether plastic “foreign” surface can result in increased cytokine 
activity on it’s own one aliquot of blood from each blood sample was incubated for 6 
hrs at 370C in a sterile plastic tube. As a positive control for surgery/CPB-induced 
inflammatory response, aliquots of blood were spiked with increasing concentrations 
of LPS (1, 10, 100, 1000 ng/ml) and were incubated for 6 hrs at 370C, prior to 
obtaining LPS-stimulated plasmas.   
 Individual cytokines and their respective modulators were assayed in patient 
plasma using the specific quantitative enzyme immunoassay ELISA for IL-1β, IL-1ra, 
TNFα or sTNF RI and RII.  
 
Results 
 
TNFα 
TNFα levels at baseline were below the sensitivity of the immunoassay in the 
majority of the patients. TNFα levels did not increase in all but two patients 6 hours 
after CPB to the detectable range. When pre and post CPB blood samples were 
incubated for an additional 6 hours in vitro, interestingly, this further incubation 
increased TNFα levels about 10 times. Inclusion of LPS (1ng/ml) produced a 
tremendous further increase in immunogenic TNFα in pre CPB whole blood. This 
stimulatory effect of LPS was less when post CPB (obtained 6 hours after CPB) whole 
blood was incubated with LPS in vitro (p<0.05).  
  
 IL-1β 
Similarly to TNFα, IL-1β levels were detectable only in a minority of patients 
prior to surgery and CPB, and as a group did not show any significant increase after 
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CPB. Similarly to TNFα, the 6-hour in vitro incubation significantly elevated IL-1β 
levels both in the pre and to a lesser degree in the post CPB blood even in the 
absence of LPS. LPS stimulation produced more than hundred fold increase in IL-1β.  
Treatment of post CPB blood with LPS under identical conditions increased IL-1β 
levels to a lesser degree (p<0.05).   
 
Soluble TNF receptors 
 Levels of the sTNF RI and sTNF RII were detectable in the nanogram range in 
all patient, which increased significantly 6 hours after CPB (p<0.05). Further 
incubation of any of the patient’s whole blood either in the presence or absence of 
LPS did not appear to change sTNF RI and sTNF RII receptor levels.  
 
 Receptor antagonists 
 IL-1ra levels after CPB were 10-90 fold higher than their respective pre CPB 
value in nearly all individual patients. Treatment of pre CPB whole blood with LPS 
significantly increased IL-1ra levels about ten fold. LPS also had a small incremental 
effect in increasing IL-1ra levels in the post CPB which already contained high levels 
of this protein. 
 
 sTNF RI : TNFα  és sTNF RII : TNFα molar ratios 
Molar plasma concentrations of both sTNF RI and II were at least two orders of 
magnitude higher than corresponding concentrations of TNF providing a median ratio 
of 449 for sTNF RI/TNF and 465 for sTNF RII/TNF.  These molar ratios increased 
further 6 hours after CPB due to increase in sTNF RI and RII over TNF. These ratios 
decreased following in vitro incubation of pre CPB whole blood even in the absence of 
LPS because the increase in TNF was more prominent than the increase in sTNF RI 
and RII. LPS activation dramatically reduced these ratios producing a situation where 
concentrations of TNF now exceeded the concentration of sTNF RI and RII by an 
order of magnitude. Similar changes were seen in the post CPB blood, although the 
effects of in vitro incubations were less pronounced.   
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IL-1ra : IL-1β molar ratios     
 Analyses of the molar ratios reveals a 350 fold pre-dominance of IL-1ra over IL-
1β before CPB. This ratio increased tremendously following CPB although individual 
patients exhibited more than an order of magnitude variability. In sharp contrast to the 
in vivo data, the whole blood in vitro assay produced decreases in these ratios due to 
predominant stimulated release of IL-1β over IL-1ra. In the presence of LPS, this ratio 
decreased to 5 and 36 in the pre and post CPB samples, respectively (p<0.05) 
  
New observations 
 
1. We demonstrated that the patients present for cardiac surgery with huge molar 
excess of anti-inflammatory cytokines. On the basis of these calculations there were 
more than 800 circulating sTNF RI and sTNF RII molecules for every molecule of 
TNF. Similarly to the TNF pathway, there was a 400 fold molar excess of IL-1ra over 
IL-1β. These observations suggest that the plasma of patients presented for open-
heart surgery is equipped with a formidable repertoire to attenuate pro-inflammatory 
cytokine action, representing a tremendous physiologic reserve that might have the 
capacity to prevent widespread organ damage after heart operations.  
 
2. Our data do not support the hypothesis that surgery/CPB up regulates the early 
response pro-inflammatory cytokines creating a pro-inflammatory imbalance in the 
plasma. Instead, our results substantiate previous observations regarding anti-
inflammatory response to coronary surgery and/or CPB, involving soluble inhibitors of 
TNF and the soluble receptor antagonist of IL-1. In contrast to anti-inflammatory 
events, there was no evidence for statistically significant increases in either TNF or IL-
1 concentrations at any time points following CPB when compared to pre-surgery 
levels. 
 
3. In contrast to our in vivo results under our experimental conditions (6 hours 
incubation at 37o C in sterile plastic tube) we have found consistent increases in both 
IL-1 and TNF concentrations causing reduced anti/pro-inflammatory ratios when 
compared to levels prior to these incubations in the native plasma. Thus, prolonged 
exposure of the stagnant whole blood to foreign plastic surface readily activated blood 
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cells to release these cytokines under the conditions of the experiment. In response to 
LPS the observed increase of IL-1 and TNF release was significantly less in the 
postoperative samples (endotoxin tolerance).   
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INFLUENCE OF PRO-INFLAMMATORY CYTOKINES AND PATIENT’S 
PLASMA ON HUMAN VASCULAR ENDOTHELIAL CELL DEATH 
 
 
In this section we compared the influence of TNFα and IL-1β cytokines and 
bacterial LPS to patient’s native and LPS-induced plasma before and after CPB on 
human endothelial cells in culture. Our major aim was to elucidate whether routine 
cardiac surgery involving CPB causes any imbalance of pro/anti-inflammatory and 
pro-apoptotic/cytoprotective bioactivities in the blood of patients that alters the viability 
of human vascular endothelial cells. 
 
Methods 
 
Human aortic (HAEC) or pulmonary artery endothelial cells (PAEC) were 
isolated from the aortic or pulmonary artery trimmings from heart and heart/lung 
donors. For experiments cells were seeded into 24 well plates and allowed to grow to 
80% confluence. Endothelial cells were identified by their characteristic monolayer 
appearance ad by immunocytochemical staining.  
 
 Apoptosis bioassay 
In order to assess the direct influence of cytokines and LPS on endothelial cell 
morphology and viability, human aortic endothelial cells were treated in the absence or 
presence of cycloheximide (10 µM) with increasing concentrations of TNF, IL- 1B and 
LPS for 6 hours. The effects of single cytokines were compared to native patient 
plasma obtained before and after CPB or to serial dilutions of plasma of LPS 
stimulated whole blood obtained before and after CPB.  At the end of the incubation 
period cells were assessed for morphological criteria of apoptosis using phase 
contrast microscopy and for viability using the MTT assay.  The role of apoptosis in 
endothelial cell injury was tested by investigating the role of endogenous caspases in 
mediating decreased viability. This was achieved by incubating the cells in the 
absence or presence of the cell-permeable peptide, z-VAD, a highly specific caspase 
inhibitor and by assessment of its influence on cytokine- and plasma-induced cell 
death.  
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Results 
 
Cytokine-induced endothelial apoptosis in sensitised cells 
In the absence of cycloheximide, there was no obvious morphological change 
observed in human aortic endothelial cells treated with TNF, IL-1 and LPS and there 
was no change in cell viability as assessed by the MTT assay. In the presence of 
CHX, the TNF induced cell activation and induction of cell death was unmasked, 
showing a concentration-dependent inhibition in cell viability over 6 hours. Similar 
concentration-dependent decreases in cell viability and morphological changes were 
observed with IL-1. LPS only caused cytotoxicity at concentrations higher that 10 
ng/ml. The decrease in viability and apoptotic morphology exhibited by the endothelial 
cells was inhibited by  ZVAD. 
 
Influence of patient plasma samples  on HAEC apoptosis 
There was a small and variable degree of reduction in HAEC viability in 
response to post CPB plasma when compared to the appropriate pre CPB plasma 
samples. In contrast, significant bioactivity to cause endothelial cell death was 
observed in the plasmas obtained from the LPS-stimulated whole bloods. This activity 
was present even at 1:100 fold dilutions of the LPS-stimulated plasmas. Again, ZVAD 
completely prevented HAEC cytotoxicity induced by all LPS-activated plasma 
samples.  
Finally, we compared the influence of LPS on the pre and post CPB blood 
samples. Although LPS produced a concentration dependent cytotoxic activity in both 
the pre- and post-CPB whole blood, cytotoxicity induced by the post CPB plasmas 
was significantly less at all LPS concentrations.  
 
New observations 
 
1. Using human endothelial cells in vitro bioassay we failed to demonstrate 
severe cytotoxic activity in patients’ plasma after routine cardiac surgery utilizing CPB.  
On the other hand, concentration-dependent cytotoxic/apoptotic activity induced by 
bacterial LPS was significantly less in the post CPB plasmas than in the preoperative 
samples.  
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BASAL AND NITROGLYCERIN-INDUCED EXHALED NITRIC OXIDE IN 
OPEN-HEART CARDIAC SURGERY 
 
 
Nitric Oxide (NO) plays an important role in both the physiological control of 
lung function and in the pathophysiology of several lung diseases.   
As endogenous production of NO can be detected and monitored in the 
exhaled air it has become a valuable diagnostic and monitoring tool in acut and 
chronic lung pathologies. Previous studies suggest that expired NO is mainly of airway 
epithelial rather than of vascular endothelial origin, what would mean that altered 
pulmonary microvascular function might not be reflected by a change in expired NO. 
However, endogenous NO pathways can be augmented by administration of 
NO donors, such as nitroglycerin (GTN), which elicits its biological effect by NO 
release mediated by thiol-dependent enzymatic biotransformation in the pulmonary 
microvasculature. NO then diffuses into the alveolar space, giving measurable rise to 
exhaled NO. On the basis of these considerations, GTN-induced exhaled NO might be 
a useful tool to monitor metabolic function of pulmonary microvasculature. 
The aim of this study was to clarify the characteristics of NO in the expired air in 
the setting of routine open-heart surgery utilizing CPB. In addition we contrasted 
airway epithelial mechanisms (reflected as basal exhaled NO) to vascular events 
(judged by exhaled NO responses following intravenous administration of GTN).  
 
Methods 
 
Breath to breath measurements of NO concentrations in the lower airways were 
performed using a real-time, computer-controlled and integrated system (LR2000 
series, Logan Research Ltd.). Inspired and expired samples for analysis of NO, CO 
and CO2 were continuously withdrawn directly from the main lower airways through a 
thin Teflon sampling tube. Since detected concentration of exhaled gases depends on 
both the production rate and ventilation parameters, ventilation was standardized for 
inspired gas (100% O2), tidal volume (5 ml/kg), respiratory rate (10/min), inspiratory 
and expiratory ratio (1:3) and PEEP set to zero.  
Baseline measurements were performed prior to CPB to evaluate endogenous 
levels of exhaled NO. After the baseline measurements, three increasing boluses of 1, 
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2 and 3 µg/kg GTN were administered to the patient via the central venous catheter 
with exhaled NO response recorded. The similar protocol was repeated 1and 3 hours 
after CPB.  
 
 Results 
  
In all patients NO was detectable in the exhaled air before CPB as a 
characteristic oscillating signal, which appeared to increase with expiration as judged 
by the CO2.  
Basal (endogenous) exhaled NO levels and exhaled CO levels remained 
unchanged 1 and 3 hours after CPB.  
Intravenous bolus administration of 1, 2 and 3 µg/kg GTN resulted in a rapid, 
transient and dose-dependent increase in exhaled levels of NO. The time between 
administration of GTN bolus and detectable rise in exhaled NO was about 10-12 
seconds and lasted for only a couple of breathe cycles. 
There were characteristic changes in GTN-induced response in exhaled NO 
after CPB. The dose-dependent increases in exhaled NO by GTN were significantly 
smaller at 1 hour and 3 hours after CPB when compared to levels measured before 
CPB. As an internal control, we analysed the CO2 output data to ensure that the 
changes regarding GTN-induced exhaled NO post CPB was not due to changes in 
exhalation profiles. This analysis reveals that baseline peak exhaled CO2 was similar 
before, 1 and 3 hours after CPB and similarly, end tidal CO2 remained the same for 
each respective GTN boluses before and after CPB.  
 
New observations 
 
1. While basal NO production mainly of epithelial origin remained unchanged in 
the perioperative period, our results indicate attenuation of the metabolic activity of 
lungs to increase exhaled NO in response to intravenous GTN following CPB, 
suggesting a degree of selective microvascular injury even in routine open-heart 
surgery.  
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